Why the study?
Certain types of lipids trigger cardiac lipotoxicity and ultimately heart failure, highlighting the need to review advances in pathogenesis and treatment prospects for lipotoxic cardiomyopathy.
Key points are not available for this paper at this time.
Design
Review
Lipid disorders may promote cardiac lipotoxicity and HF progression; leaves open specific therapeutic targets for clinical trials.
Fatty acids are the primary fuel for cardiac muscle. The physiological equilibrium of lipid uptake and oxidation may aid in the prevention of excessive lipid accumulation. Several pathological states, such as myocardial ischemia, obesity, and insulin resistance, are routinely associated with disorders of lipid metabolism. There is growing evidence that certain types of lipids trigger cardiac lipotoxicity and ultimately heart failure. This review focuses on recent advances in the pathogenesis of lipotoxic cardiomyopathy and the treatment prospects for the repair of cardiac damage caused by lipotoxicity.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: